Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

797 ARTÍCULOS , VIENDO DEL 751 AL 765

Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics

Villain N, Planche V, Lilamand M, Cordonnier C, Soto-Martin M, Mollion H, Bombois S, Delrieu J; French Federation of Memory Clinics Work Group on Anti-Amyloid Immunotherapies.

J Prev Alzheimers Dis. 2025 Apr;12(4):100094. doi: 10.1016/j.tjpad.2025.100094. Epub 2025 Feb 25.

Neuroinflammatory fluid biomarkers in patients with Alzheimer's disease: a systematic literature review

Heneka MT, Gauthier S, Chandekar SA, Hviid Hahn-Pedersen J, Bentsen MA, Zetterberg H.

Mol Psychiatry. 2025 Jun;30(6):2783-2798. doi: 10.1038/s41380-025-02939-9. Epub 2025 Mar 6.

Overview of Alzheimer's Disease Neuroimaging Initiative and future clinical trials

Weiner MW, Kanoria S, Miller MJ, Aisen PS, Beckett LA, Conti C, Diaz A, Flenniken D, Green RC, Harvey DJ, Jack CR Jr, Jagust W, Lee EB, Morris JC, Nho K, Nosheny R, Okonkwo OC, Perrin RJ, Petersen RC, Rivera-Mindt M, Saykin AJ, Shaw LM, Toga AW, Tosun D, Veitch DP; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2025 Jan;21(1):e14321. doi: 10.1002/alz.14321. Epub 2024 Dec 22.

Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison

Pilotto A, Quaresima V, Trasciatti C, Tolassi C, Bertoli D, Mordenti C, Galli A, Rizzardi A, Caratozzolo S, Zancanaro A, Contador J, Hansson O, Palmqvist S, De Santis G, Zetterberg H, Blennow K, Brugnoni D, Suárez-Calvet M, Ashton NJ, Padovani A.

Brain. 2025 Feb 3;148(2):408-415. doi: 10.1093/brain/awae368.

New landscape of the diagnosis of Alzheimer's disease

Frisoni GB, Hansson O, Nichols E, Garibotto V, Schindler SE, van der Flier WM, Jessen F, Villain N, Arenaza-Urquijo EM, Crivelli L, Fortea J, Grinberg LT, Ismail Z, Minoshima S, Ossenkoppele R, Zetterberg H, Petersen RC, Dubois B.

Lancet. 2025 Sep 27;406(10510):1389-1407. doi: 10.1016/S0140-6736(25)01294-2. Epub 2025 Sep 22.

Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings

Palmqvist S, Whitson HE, Allen LA, Suarez-Calvet M, Galasko D, Karikari TK, Okrahvi HR, Paczynski M, Schindler SE, Teunissen CE, Zetterberg H, Carrillo MC, Edelmayer RM, Mahinrad S, McAteer MB, Kahale LA, Pahlke S, Tampi MP.

Alzheimers Dement. 2025 Jul;21(7):e70535. doi: 10.1002/alz.70535.

Pathogenesis of comorbid epilepsy in Alzheimer's disease and use of perampanel, an AMPA receptor inhibitor

Kuzuya A, Ohara T, Akamatsu N.

Expert Rev Neurother. 2025 Dec;25(12):1399-1409. doi: 10.1080/14737175.2025.2581758. Epub 2025 Oct 30.

Alzheimer, Parkinson, dementia, and phytochemicals: insight review

Can B, Sanlier N.

Crit Rev Food Sci Nutr. 2025;65(9):1706-1728. doi: 10.1080/10408398.2023.2299340. Epub 2024 Jan 8.

The Neuro-Healing Frontier: Alpha-Mangostin's Potential in Alzheimer's and Parkinson's Treatment

Goyal A, Agrawal N, Agrawal N, Verma A, Solanki K, Yadav HN.

Comb Chem High Throughput Screen. 2025;28(12):1989-1999. doi: 10.2174/0113862073311357240626103752.

Heavy metals exposure and Alzheimer's disease: Underlying mechanisms and advancing therapeutic approaches

Althobaiti NA.

Behav Brain Res. 2025 Jan 5;476:115212. doi: 10.1016/j.bbr.2024.115212. Epub 2024 Aug 24.

"Current and emerging drug therapies in Alzheimer's disease: A pathophysiological Perspective"

Aparajita A, Jain U, Srivastava P.

Neuroscience. 2025 Jan 26;565:499-518. doi: 10.1016/j.neuroscience.2024.11.078. Epub 2024 Dec 9.

Targeting tau in Alzheimer's and beyond: Insights into pathology and therapeutic strategies

Singh S, Khan S, Shahid M, Sardar M, Hassan MI, Islam A.

Ageing Res Rev. 2025 Feb;104:102639. doi: 10.1016/j.arr.2024.102639. Epub 2024 Dec 16.

Ginsenosides Rg1, Rb1 and rare ginsenosides: Promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis

Jiang M, Chi J, Qiao Y, Wang J, Zhang Z, Liu J, Sheng X, Yuan L.

Pharmacol Res. 2025 Feb;212:107578. doi: 10.1016/j.phrs.2025.107578. Epub 2025 Jan 3.

Beyond amyloid plaque, targeting α-synuclein in Alzheimer disease: The battle continues

Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Al-Gareeb AI, Albuhadily AK, Ali AA, Abu-Alghayth MH.

Ageing Res Rev. 2025 Mar;105:102684. doi: 10.1016/j.arr.2025.102684. Epub 2025 Feb 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias